Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH.

Clin Cancer Res. 2003 Sep 15;9(11):4108-15.

2.

Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.

Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M.

Jpn J Clin Oncol. 2005 Apr;35(4):188-94. Review.

PMID:
15845567
3.

Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.

Vogt HG, Martin T, Kolotas C, Schneider L, Strassmann G, Zamboglou N.

Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-101-S12-105. Review.

PMID:
9331131
4.
5.

The clinical development of paclitaxel and the paclitaxel/carboplatin combination.

Schwartz GN, Pendyala L, Kindler H, Meropol N, Perez R, Raghavan D, Creaven P.

Eur J Cancer. 1998 Sep;34(10):1543-8. Review.

PMID:
9893625
6.

Experience of treatment of lung cancer patients using paclitaxel and carboplatin.

Jusuf A, Mariono SA, Tambunan KL, Reksodiputro AH, Soetandyo N, Hukom R, Suratman E, Jayusman AM.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:454-60. Review.

PMID:
10895195
7.

Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.

Rosell R, Felip E.

Semin Oncol. 2001 Aug;28(4 Suppl 14):37-44. Review.

PMID:
11605182
8.

Advanced non-small cell lung cancer.

Edelman MJ, Khanwani SL.

Curr Treat Options Oncol. 2001 Feb;2(1):51-62. Review.

PMID:
12057140
9.

Preliminary results of combined therapy with topotecan and carboplatin in advanced non-small-cell lung cancer.

Pujol JL, von Pawel J, Tumolo S, Martoni A, Hearn S, Fields SZ, Ross G.

Oncology. 2001;61 Suppl 1:47-54. Review.

PMID:
11598415
10.

Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.

Hainsworth JD, Burris HA 3rd, Greco FA.

Semin Oncol. 2001 Apr;28(2 Suppl 4):43-7. Review.

PMID:
11479897
11.

Angiogenesis inhibitors in the treatment of lung cancer.

Shepherd FA.

Lung Cancer. 2001 Dec;34 Suppl 3:S81-9. Review.

PMID:
11740999
12.

Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.

Shepherd FA, Eisenhauer E.

Semin Oncol. 1998 Feb;25(1 Suppl 2):2-7. Review.

PMID:
9535204
13.

Weekly paclitaxel in the treatment of metastatic and/or recurrent non-small cell lung cancer.

Alberola V, Cortesi E, Juan O.

Crit Rev Oncol Hematol. 2002 Dec 27;44 Suppl:S31-41. Review.

PMID:
12505597
14.

Carboplatin and paclitaxel in non-small cell lung cancer: the role of amifostine.

Selvaggi G, Belani CP.

Semin Oncol. 1999 Apr;26(2 Suppl 7):51-60. Review.

PMID:
10348261
15.

Preoperative paclitaxel plus carboplatin for patients with intermediate-risk non-small cell lung cancer.

Ruckdeschel JC.

Semin Oncol. 1996 Dec;23(6 Suppl 16):62-7. Review.

PMID:
9007125
16.

The role of chemotherapy in early non-small-cell lung cancer management.

Rosell R, Felip E, Maestre J, Sanchez JM, Sanchez JJ, Manzano JL, Astudillo J, Taron M, Monzo M.

Lung Cancer. 2001 Dec;34 Suppl 3:S63-74. Review.

PMID:
11740997
17.

Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer.

Greco FA.

Lung Cancer. 2001 Dec;34 Suppl 4:S53-6. Review.

PMID:
11742703
18.

Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.

Sandler A.

Oncology (Williston Park). 2003 Nov;17(11 Suppl 12):17-22. Review.

19.

Paclitaxel via 1-hour infusion: clinical experience.

Greco FA, Hainsworth JD.

Semin Oncol. 1996 Dec;23(6 Suppl 16):91-3. Review.

PMID:
9007131
20.

Paclitaxel-based therapy in non-small-cell lung cancer: improved third generation chemotherapy.

Greco FA, Hainsworth JD.

Ann Oncol. 1999;10 Suppl 5:S63-7. Review.

PMID:
10582142

Supplemental Content

Support Center